• Seeking Alpha

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

Seeking Alpha / 42 minutes ago 1 Views

- Renowned neuroscience drug developer joins to support strategic development
of long-acting CNS therapeutics –

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Next post
Cal Redwood Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

Comments

Just Posted

  • El servicio nacional Drones como un Servicio (DaaS) de ZenaTech crece con el cierre de su quinta adquisición, sumando capacidades de inspección de líneas eléctricas

    3 hours from now

  • Brompton Split Banc Corp. Renews At-the-Market Equity Program

    3 hours from now

  • Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock

    3 hours from now

  • Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition

    3 hours from now

  • Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025

    2 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1301

Categories

  • Seeking Alpha 1301

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts